EuroImmun Receives FDA EUA for Covid-19 RT-PCR Test
The assay is authorized for use with upper respiratory specimens collected from individuals suspected by their healthcare provider to have covid-19.
Read MorePosted by Laurie Bonner | Jun 23, 2020 | Uncategorized |
The assay is authorized for use with upper respiratory specimens collected from individuals suspected by their healthcare provider to have covid-19.
Read MorePosted by Laurie Bonner | Jun 23, 2020 | Covid 19 |
Features of the kit include 1.5-hour testing time from preparation to finish, 94-sample capacity, and a limit of detection of 1.2 copies of SARS-CoV-2 RNA per µL.
Read MorePosted by Laurie Bonner | Jun 22, 2020 | Covid 19 |
A pipetting robot from Denmark is automating covid-19 testing processes in hospitals around Europe.
Read MorePosted by Laurie Bonner | Jun 22, 2020 | Covid 19 |
Covid-19 Diagnostics Evidence Accelerator is a multi-stakeholder collaborative project to advance the development of diagnostics.
Read MorePosted by Laurie Bonner | Jun 22, 2020 | Covid 19 |
The initiative—in partnership with TestDirectly, Northwest Laboratory, and the Florida DOH—is expected to test 500,000 patient specimens.
Read More